Immunotherapy

How the IsoLight/IsoSpark can support a research lab’s pursuit of novel immunotherapies

Consider these key factors for a successful, reproducible flow cytometry assay

Single-cell proteomics can predict resistance and enable therapies to combat drug-resistant cell states

Functional proteomics provides a complete picture of the mechanisms involved in the patient response

Research shows bacteria residing within tumors can be harnessed to provoke an immune reaction against the tumor

The results provide a clearer picture of how kidney tumor microenvironments change in response to immunotherapy

The novel immunotherapy approach uses bispecific antibodies against mutant proteins to target cancer cells

This is the first randomized study to report on the role of combination checkpoint inhibitors for early stage NSCLC

Study shows how chemicals in the tumor microenvironment subvert the immune system, enabling cancer to evade attack

The biomarkers could help discriminate treatment-associated kidney injury from other causes, guiding treatment